```

Exhibit 31
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

                                 CERTIFICATION

I, Rik J. Deitsch, Chief Executive Officer and Chief Financial Officer of
Nutra Pharma Corp., certify that:

1. I have reviewed this quarterly report on Form 10-QSB for the fiscal quarter
ended March 31, 2005, of Nutra Pharma Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. As the registrant's certifying officer(s), I am responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:

     a.  Designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure controls and procedures to be designed under my supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

     b. Designed such internal control over financial reporting,  or caused such
internal control over financial reporting to be designed under my supervision,
to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;

     c. Evaluated the effectiveness of the registrant's  disclosure controls and
procedures and presented in this report my conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

     d. Disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and

5. As the registrant's  certifying  officer(s),  I have disclosed,  based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

     a. All significant  deficiencies  and material  weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

     b. Any fraud,  whether or not material,  that involves  management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: May 26, 2005

/s/ Rik J. Deitsch
    Rik J. Deitsch
    Chief Executive Officer and Chief Financial Officer
```